Stifel Financial’s Theratechnologies THTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-79,596
Closed -$188K 3647
2025
Q2
$188K Sell
79,596
-500
-0.6% -$1.23K ﹤0.01% 3268
2025
Q1
$112K Buy
80,096
+3,150
+4% +$5.26K ﹤0.01% 3284
2024
Q4
$139K Sell
76,946
-3,900
-5% -$5.3K ﹤0.01% 3220
2024
Q3
$100K Hold
80,846
﹤0.01% 3242
2024
Q2
$113K Buy
80,846
+8,875
+12% +$11.8K ﹤0.01% 3199
2024
Q1
$119K Buy
71,971
+2,913
+4% +$4.67K ﹤0.01% 3178
2023
Q4
$112K Sell
69,058
-20,000
-22% -$30.1K ﹤0.01% 3152
2023
Q3
$191K Buy
+89,058
New +$191K ﹤0.01% 3000

Other funds holding THTX

Stifel Financial's THTX Position: Q3 2025 in Review

Stifel Financial sold out of Theratechnologies (THTX) in Q3 2025, closing a stake of 79,596 shares — an estimated $188K sold.

Stifel Financial first reported a position in THTX in Q3 2023 and held it in 8 quarters. The position peaked at $191K in Q3 2023. 10 funds tracked by Wall St. Rank hold THTX as of Q3 2025.

  • Stifel Financial reported no remaining Theratechnologies position as of Q3 2025 after selling out during the quarter.
  • Stifel Financial sold 79,596 Theratechnologies shares in Q3 2025, an estimated $188K.
  • Stifel Financial first reported a position in Theratechnologies in Q3 2023 and held it in 8 quarters.
  • Stifel Financial's Theratechnologies position peaked at $191K in Q3 2023.
  • 10 funds tracked by Wall St. Rank held Theratechnologies as of Q3 2025.

Based on Stifel Financial's 13F filing for Q3 2025, filed 12 Nov 2025.